[1]
E. Ntoukaki, V. Baltatzidou, and K. Lazaridis, “A Promising Antigen-specific Immunotherapy for the Treatment of Myasthenia Gravis”, rrnmf, vol. 4, no. 3, Aug. 2023, doi: 10.17161/rrnmf.v4i3.19494.